The new edition of the definitive,
standard-setting reference in the field.
DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 11th Edition
Vincent T. DeVita, Jr., MD
Theodore S. Lawrence, MD, PhD
Steven A. Rosenberg, MD, PhD
The 11th Edition of this gold standard text keeps you fully up to date for the life of the edition. Every quarter, your eBook will be updated with late-breaking developments in oncology, including new drugs, clinical trials, and more.
Now updated quarterly for the life of the edition, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 11th Edition, carries on a tradition of excellence while keeping you continually up to date in this fast-changing field. Every quarter, your eBook will be updated with late-breaking developments in oncology, including new drugs, clinical trials, and more. These quarterly updates ensure that your purchase remains fresh and relevant to your practice—a unique, living reference to enhance and improve your patient care.
PART II: Etiology and Epidemiology of Cancer
SECTION 1. ETIOLOGY OF CANCER
SECTION 2. EPIDEMIOLOGY OF CANCER
PART III: Cancer Therapeutics
PART IV: Cancer Prevention and Screening
PART V: Practice of Oncology
SECTION 1. CANCER OF THE HEAD AND NECK
SECTION 2. CANCER OF THE THORACIC CAVITY
SECTION 3. CANCERS OF THE GASTROINTESTINAL TRACT
SECTION 4. CANCERS OF THE GENITOURINARY SYSTEM
SECTION 5. GYNECOLOGIC CANCERS
SECTION 6. CANCER OF THE BREAST
SECTION 7. CANCER OF THE ENDOCRINE SYSTEM
SECTION 8. SARCOMAS OF SOFT TISSUE AND BONE
SECTION 9. CANCERS OF THE SKIN
SECTION 10. NEOPLASMS OF THE CENTRAL NERVOUS SYSTEM
SECTION 11. CANCERS IN ADOLESCENTS AND YOUNG ADULTS
SECTION 12. LYMPHOMAS IN ADULTS
SECTION 13. LEUKEMIAS AND PLASMA CELL TUMORS
SECTION 14. OTHER CANCERS
SECTION 15. ONCOLOGIC EMERGENCIES
SECTION 16. TREATMENT OF METASTATIC CANCER
SECTION 17. STEM CELL TRANSPLANTATION
SECTION 18. MANAGEMENT OF ADVERSE EFFECTS OF TREATMENT
PART VI: Palliative and Alternative Care
SECTION 1. SUPPORTIVE CARE AND QUALITY OF LIFE
SECTION 2. COMPLEMENTARY, ALTERNATIVE, AND INTEGRATIVE THERAPIES
Vincent T. DeVita, Jr., MD, is the Amy and Joseph Perella Professor of Medicine at the Yale Cancer Center and Professor of Epidemiology and Public Health, and was formerly the Director of the Yale Cancer Center from 1993 to 2003. Dr. DeVita has earned international recognition for his accomplishments as a pioneer in the field of oncology. His professional accomplishments include developing a combination chemotherapy program that led to curative chemotherapy for Hodgkin's disease and diffuse large cell lymphomas and developing the MOPP four-drug combination which increased the cure rate for patients with advanced Hodgkin's disease from nearly zero to over 70%. Dr. DeVita currently serves on the editorial boards of numerous scientific journals and is the author or co-author of more than 450 scientific articles.
Theodore S. Lawrence, MD, PhD, FASTRO, FASCO, is the Isadore Lampe Professor and Chair of the Department of Radiation Oncology at the University of Michigan, Ann Arbor. He is Immediate Past President of the Radiation Oncology Institute and Immediate Past Chair of the Radiation Sciences and Medicine Working Group of the American Association of Cancer Research (AACR). Dr. Lawrence is an editor of the Cancer Journal, the associate editor of Seminars in Radiation Oncology, a senior editor for Cancer Research, and a scientific editor for Cancer Discovery. He has received numerous awards, has authored more than 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 25 years.
Steven A. Rosenberg, MD, PhD, is Chief of Surgery at the National Cancer Institute in Bethesda, Maryland and a Professor of Surgery at the Uniformed Services University of Health Sciences and at the George Washington University School of Medicine and Health Sciences in Washington, D.C. He is a Professor in the Department of Laboratory Medicine at the Karolinska Institute in Stockholm, Sweden. Dr. Rosenberg pioneered the development of immunotherapy that resulted in the first effective immunotherapies for patients with advanced cancer. He also pioneered the development of gene therapy and was the first to successfully insert foreign genes into humans. In recent work, Dr. Rosenberg established new approaches for the application of immunotherapy to patients with a variety of common solid cancers by targeting the unique mutations present in the patient’s cancer. Dr. Rosenberg has received numerous awards and has published over 1100 papers in the peer-reviewed literature.
Chapter 1: The Cancer Genome
Chapter 3: Hallmarks of Cancers
Additional essential chapters exclusive to the 11th Edition: Chapter 17:Cancer Immunotherapy and Chapter 32: Immunotherapy Agents — both are detailed, authoritative summaries of the current state of the field.